Science Group at J.P. Morgan Healthcare 2020
The healthcare sector is a major focus for Science Group (AIM:SAG) a leading global, science-led advisory and product development organization. Science Group’s operating companies provide innovation services to medtech companies across the patient care continuum from the front end of innovation through go-to-market.
Oakland Innovation provides front-end-of innovation services to clients such as tech-scouting; product roadmapping and horizon scanning. In the last year we helped a number of clients develop and define value propositions especially around their digital offerings.
Sagentia is part of the Cambridge (UK) cluster of R&D development companies and provides ISO 13485 accredited product development services to a wide variety of clients, large and small. We have specific focuses in diagnostics, digital health, cell & gene therapy scale-up and development of medical devices more broadly.
TSG Consulting advises clients on regulatory issues related to taking medical devices to market. Over the last year, we have guided clients through successful 510(k) presubmission meetings for Class 2 medical devices, prepared 510(k) application packages for submission, and have advised a number of clients on optimal strategies for successful 510(k) submissions.
Case studies and insights from across the Group
About Science Group
Science Group plc is an international consulting services group supporting the entire product innovation lifecycle. The Group enables our clients to deliver on their investments in R&D. Our services include: applied science, product development, advisory and regulatory. These are combined with vertical market expertise in medical, food & beverage, industrial, chemical, energy and consumer sectors. With offices throughout Europe and North America and staff fluent in over 30 languages Science Group supports a global client base in over 100 countries.